Closes in 143 days Research and Knowledge Services

Mitigating Antimalarial Resistance Consortium in South-East Africa (MARC SE-Africa)

Summary · 1 min read

The University of Cape Town is leading a multi-country research consortium to combat artemisinin-resistant malaria parasites in South-East Africa. The project creates predictive maps of drug resistance, co-designs regional action plans, updates malaria treatment guidelines via MAGICapp, and evaluates how effectively primary healthcare workers adopt these guidelines.

Client: UNIVERSITY OF CAPE TOWN
Closing: 31 Mar 2027Multi-year project running through March 2027 contract
Location: Cape Town, Western Cape / South-East Africa
Published: 23 Aug 2026

Download tender documents

Do you qualify? 2 requirements found

Extracted from the tender documents by AI · check against the official notice

Demonstrated expertise in malaria research and healthcare policy translation
Mandatory
Institutional capacity to conduct multi-national health research in South-East Africa
Mandatory

Documents you must submit

Research Implementation Plan
Consortium Partner Agreements
Ethics Clearances and Regulatory Compliance Documentation

Evaluation criteria

Evaluated based on Horizon Europe / EDCTP standards for scientific excellence, regional impact, implementation capacity, and healthcare policy integration.